HeartBeam, Inc. financial data

Symbol
BEAT, BEATW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2118 Walsh Ave., Suite 210, Santa Clara, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 13.3 % -2%
Return On Equity -176 % -24.9%
Return On Assets -155 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.7M shares +1.28%
Common Stock, Shares, Outstanding 26.6M shares +1.02%
Entity Public Float 21.4M USD +232%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.8M shares +1.15%
Weighted Average Number of Shares Outstanding, Diluted 26.8M shares +1.15%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 10.2M USD +58.3%
General and Administrative Expense 8.88M USD +4.24%
Operating Income (Loss) -19.1M USD -27.5%
Nonoperating Income (Expense) 632K USD +34.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.4M USD -27.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -18.4M USD -27.3%
Earnings Per Share, Basic -0.48 USD/shares +61.3%
Earnings Per Share, Diluted -0.48 USD/shares +61.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.77M USD -69.9%
Cash, Cash Equivalents, and Short-term Investments 19.2M USD
Assets, Current 6.14M USD -68.5%
Property, Plant and Equipment, Net 457K USD +217%
Other Assets, Noncurrent 56K USD +124%
Assets 6.66M USD -66.1%
Liabilities, Current 1.86M USD
Liabilities 1.86M USD +82.1%
Retained Earnings (Accumulated Deficit) -51.4M USD -55.9%
Stockholders' Equity Attributable to Parent 4.8M USD -74.2%
Liabilities and Equity 6.66M USD -66.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.46M USD -11.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -88K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 26.6M shares +1.02%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.55M USD -36.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.82M USD -69.7%
Deferred Tax Assets, Valuation Allowance 9.09M USD +50.3%
Deferred Tax Assets, Gross 9.09M USD +50.3%
Payments to Acquire Property, Plant, and Equipment 88K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.8M USD +40.9%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 287K USD +61%
Additional Paid in Capital 56.2M USD +8.9%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.49M USD +89.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%